Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


11.10.2021

1 Am J Pathol
1 Ann Intern Med
2 Br J Surg
1 Cancer
1 Cancer Res
2 Gut
6 Hepatology
1 J Comput Assist Tomogr
1 J Gastroenterol Hepatol
10 J Hepatol
1 PLoS Med
3 PLoS One
1 Radiology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Pathol

  1. BARAJAS JM, Lin CH, Sun HL, Alencastro F, et al
    METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm-Controlled Gene Expression in Mice.
    Am J Pathol. 2021 Sep 29. pii: S0002-9440(21)00430.
    PubMed         Abstract available


    Ann Intern Med

  2. TRAN AN, Lim JK
    Care of the Patient With Abnormal Liver Test Results.
    Ann Intern Med. 2021;174:ITC129-ITC144.
    PubMed         Abstract available


    Br J Surg

  3. ISONIEMI H, Uutela A, Nordin A, Lantto E, et al
    Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Br J Surg. 2021;108:817-825.
    PubMed         Abstract available

  4. SNEIDERS D, Boteon APCS, Lerut J, Iesari S, et al
    Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis.
    Br J Surg. 2021 Oct 6. pii: 6382003. doi: 10.1093.
    PubMed         Abstract available


    Cancer

  5. CHENG K, Chen Y, Wang X, Xu M, et al
    Entecavir combined with interferon-alpha is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B.
    Cancer. 2021 Oct 8. doi: 10.1002/cncr.33949.
    PubMed         Abstract available


    Cancer Res

  6. BARCENA-VARELA M, Lujambio A
    A Novel Long Noncoding RNA Finetunes the DNA Damage Response in Hepatocellular Carcinoma.
    Cancer Res. 2021;81:4899-4900.
    PubMed         Abstract available


    Gut

  7. GRANDER C, Schaefer B, Schwarzler J, Grabherr F, et al
    Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humans.
    Gut. 2021;70:585-594.
    PubMed         Abstract available

  8. FROST F, Kacprowski T, Ruhlemann M, Pietzner M, et al
    Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function.
    Gut. 2020 Nov 9. pii: gutjnl-2020-322753. doi: 10.1136/gutjnl-2020-322753.
    PubMed         Abstract available


    Hepatology

  9. MCCARRON S, Bathon B, Conlon DM, Abbey D, et al
    Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH.
    Hepatology. 2021;74:1825-1844.
    PubMed         Abstract available

  10. DE ZEGHER F, Ibanez L
    Letter to the Editor: Tackling NAFLD in Adolescent Polycystic Ovary Syndrome: Reducing Liver Fat to Mimic Weight Loss.
    Hepatology. 2021;73:1623-1624.
    PubMed        

  11. GOLRIZ M, Ramouz A, Mehrabi A
    Letter to the Editor: Surgical Method for Establishing Posthepatectomy Liver Failure.
    Hepatology. 2021;73:1621.
    PubMed        

  12. SINGAL AG, Nabihah T, Mehta A, Marrero JA, et al
    GALAD Demonstrates High Sensitivity for HCC Surveillance in a Cohort of Patients with Cirrhosis.
    Hepatology. 2021 Oct 7. doi: 10.1002/hep.32185.
    PubMed         Abstract available

  13. LIU N, Steer CJ, Song G
    MicroRNA-206 Enhances Antitumor Immunity by Disrupting the Communication between Malignant Hepatocytes and Tregs in c-Myc Mice.
    Hepatology. 2021 Oct 4. doi: 10.1002/hep.32182.
    PubMed         Abstract available

  14. LAWITZ EJ, Shevell DE, Tirucherai GS, Du S, et al
    BMS-986263 in Patients with Advanced Hepatic Fibrosis: 36-Week Results from a Randomized, Placebo-Controlled Phase 2 Trial.
    Hepatology. 2021 Oct 4. doi: 10.1002/hep.32181.
    PubMed         Abstract available


    J Comput Assist Tomogr

  15. KIM Y, Hwang J, Hong SS, Kim HJ, et al
    Clinical Feasibility of High-Resolution Contrast-Enhanced Dynamic T1-Weighted Magnetic Resonance Imaging of the Upper Abdomen Using Compressed Sensing.
    J Comput Assist Tomogr. 2021;45:669-677.
    PubMed         Abstract available


    J Gastroenterol Hepatol

  16. OGAWA E, Kawano A, Ooho A, Furusyo N, et al
    Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for HCV infection.
    J Gastroenterol Hepatol. 2021 Oct 7. doi: 10.1111/jgh.15703.
    PubMed         Abstract available


    J Hepatol

  17. MULLER M, Bird TG, Nault JC
    The landscape of gene mutations in cirrhosis and hepatocellular carcinoma.
    J Hepatol. 2020 Feb 7. pii: S0168-8278(20)30060.
    PubMed         Abstract available

  18. GRONEBERG M, Hoenow S, Marggraff C, Fehling H, et al
    HIF-1alpha modulates sex-specific Th17/Treg responses during hepatic amoebiasis.
    J Hepatol. 2021 Sep 29. pii: S0168-8278(21)02082.
    PubMed         Abstract available

  19. HSIEH J, Molusky MM, McCabe KM, Fotakis P, et al
    TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion.
    J Hepatol. 2021 Sep 30. pii: S0168-8278(21)02083.
    PubMed         Abstract available

  20. GIABICANI M, Le Menestrel A, Roux O, Rautou PE, et al
    Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: a case control study from the prospective COVID-ICU database.
    J Hepatol. 2021 Sep 30. pii: S0168-8278(21)02080.
    PubMed        

  21. BAFFY G, Bosch J
    Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?
    J Hepatol. 2021 Oct 1. pii: S0168-8278(21)02090.
    PubMed         Abstract available

  22. KIM HY, Lampertico P, Nam JY, Lee HC, et al
    An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
    J Hepatol. 2021 Oct 1. pii: S0168-8278(21)02087.
    PubMed         Abstract available

  23. BEAUFRERE A, Caruso S, Calderaro J, Pote N, et al
    Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.
    J Hepatol. 2021 Oct 5. pii: S0168-8278(21)02099.
    PubMed         Abstract available

  24. GARCIA-TSAO G, Bosch J, Kayali Z, Harrison SA, et al
    Randomized Placebo-Controlled Trial of Emricasan in Non-alcoholic Steatohepatitis (NASH) Cirrhosis with Severe Portal Hypertension.
    J Hepatol. 2019 Dec 20. pii: S0168-8278(19)30724.
    PubMed         Abstract available

  25. PAISANT A, Vilgrain V, Riou J, Oberti F, et al
    Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs.
    J Hepatol. 2019 Dec 20. pii: S0168-8278(19)30725.
    PubMed         Abstract available

  26. BAJAJ JS, Khoruts A
    Microbiota changes and Intestinal Microbiota Transplantation in Liver Diseases and Cirrhosis.
    J Hepatol. 2020 Jan 28. pii: S0168-8278(20)30058.
    PubMed         Abstract available


    PLoS Med

  27. TONA LUTETE G, Mombo-Ngoma G, Assi SB, Bigoga JD, et al
    Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
    PLoS Med. 2021;18:e1003669.
    PubMed         Abstract available


    PLoS One

  28. KIM JY, Park YM, Lee GN, Song HC, et al
    Association between toothbrushing and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0243686.
    PubMed         Abstract available

  29. MAHRINGER-KUNZ A, Steinle V, Kloeckner R, Schotten S, et al
    The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study.
    PLoS One. 2021;16:e0249426.
    PubMed         Abstract available

  30. NG YZ, Lai LL, Wong SW, Mohamad SY, et al
    Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease.
    PLoS One. 2021;16:e0250300.
    PubMed         Abstract available


    Radiology

  31. CHANDARANA H, Shanbhogue K
    Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar.
    Radiology. 2021 Jan 5:204315. doi: 10.1148/radiol.2021204315.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: